share

4H-Pyrrolo[3,2-D]Isoxazole,5,6-Dihydro-3-Tricyclo[3.3.1.13,7]Dec-1-Yl-(9Ci) CAS NO 603067-75-0


Unit Price:

CAS No.:603067-75-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4H-Pyrrolo[3,2-D]Isoxazole,5,6-Dihydro-3-Tricyclo[3.3.1.13,7]Dec-1-Yl-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex, polycyclic molecular architecture. This compound matters for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting central nervous system (CNS) disorders. It is primarily needed by research institutions and pharmaceutical companies engaged in medicinal chemistry, process development, and the production of sophisticated therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug candidates, especially for neurological and psychiatric applications.
  • Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and the discovery of new bioactive molecules.
  • Process Development & Scale-Up: Used in optimizing synthetic routes from laboratory scale to pilot plant and commercial manufacturing.
  • Contract Research & Manufacturing (CRMO): Supplied to organizations specializing in custom synthesis and development services for the pharmaceutical industry.
  • Academic Research: Utilized in universities and research institutes for studies in organic synthesis methodology and heterocyclic chemistry.

Basic Information

Product Name 4H-Pyrrolo[3,2-D]Isoxazole,5,6-Dihydro-3-Tricyclo[3.3.1.13,7]Dec-1-Yl-(9Ci)
CAS No. 603067-75-0
Molecular Formula C14H18N2O
Molecular Weight 230.31 g/mol
Synonyms 3-Adamantanyl-5,6-dihydro-4H-pyrrolo[3,2-d]isoxazole; 3-Tricyclo[3.3.1.13,7]dec-1-yl-5,6-dihydro-4H-pyrrolo[3,2-d]isoxazole; 3-Adamantyl-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine; Adamantane-substituted pyrroloisoxazole; 603067-75-0; 4H-Pyrrolo[3,2-d]isoxazole, 5,6-dihydro-3-tricyclo[3.3.1.13,7]dec-1-yl-
EINECS Contact for details

Quality Control

Our 4H-Pyrrolo[3,2-D]Isoxazole,5,6-Dihydro-3-Tricyclo[3.3.1.13,7]Dec-1-Yl-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical R&D and process chemistry. Certificates of Analysis (COA) detailing batch-specific results are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms
Purity (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.